Published in Laval Med on June 01, 1970
A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia. Gastroenterology (1999) 2.11
A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc Natl Acad Sci U S A (1967) 1.23
Increase in rat brain tyrosine hydroxylase activity produced by electroconvulsive shock. Proc Natl Acad Sci U S A (1969) 1.00
A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically. Br J Pharmacol (1993) 0.98
Evidence for a role of tachykinins as sensory transmitters in the activation of micturition reflex. Neuroscience (1993) 0.94
Comparison in different tissue preparations of the in vitro pharmacological profile of RP 67580, a new non-peptide substance P antagonist. Neuropeptides (1992) 0.92
Hypotensive activity of PAF-acether in rats. Agents Actions (1982) 0.91
[Pro9]SP and [pGlu6, Pro9]SP(6-11) interact with two different receptors in the guinea-pig ileum as demonstrated with new SP antagonists. Neuropeptides (1992) 0.90
The neuroleptics. 4. Toxicity and side effects in man and in the laboratory animal. Mod Probl Pharmacopsychiatry (1970) 0.89
Studies on the immunosuppressive activity of L-asparaginase. Recent Results Cancer Res (1970) 0.89
Selective agonists of NK-2 binding sites highly active on rat portal vein (NK-3 bioassay). Neuropeptides (1991) 0.88
[Toxicologic study and experimental antitumor activity of rubidomycin (13,057 R.P.)]. Pathol Biol (1967) 0.88
Variations in affinities for the NK1 receptor: differences between the non-peptide substance P antagonists RP 67580 and CP-96,345 and the agonist septide. Regul Pept (1993) 0.88
Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580. Eur J Pharmacol (1993) 0.87
Septide: an agonist for the NK1 receptor acting at a site distinct from substance P. Mol Pharmacol (1994) 0.87
Brain receptors and zopiclone. Pharmacology (1983) 0.87
Pharmacological studies on zopiclone. Pharmacology (1983) 0.87
Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists. Eur J Pharmacol (1991) 0.86
Differences between cyclopyrrolones (suriclone and zopiclone) and benzodiazepine binding to rat hippocampus photolabelled membranes. Biochem Pharmacol (1983) 0.85
Suriclone: a new cyclopyrrolone derivative recognizing receptors labeled by benzodiazepines in rat hippocampus and cerebellum. J Neurochem (1983) 0.85
Distribution of neurokinin B in rat spinal cord and peripheral tissues: comparison with neurokinin A and substance P and effects of neonatal capsaicin treatment. Neuroscience (1992) 0.83
Characterization of a human NK1 tachykinin receptor in the astrocytoma cell line U 373 MG. J Neurochem (1993) 0.83
Partial chemical characterization of cyclopyrrolones ([3H] suriclone) and benzodiazepines ([3H]flunitrazepam) binding site: differences. Life Sci (1985) 0.82
Molecular determinants of the species selectivity of neurokinin type 1 receptor antagonists. Mol Pharmacol (1995) 0.82
The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation. Neuroscience (1995) 0.82
Some pharmacological and toxicological studies on ketoprofen. Rheumatol Rehabil (1976) 0.82
Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems. Eur J Pharmacol (1984) 0.81
Polyclonal antibodies against the rat NK1 receptor: characterization and localization in the spinal cord. Neuroreport (1992) 0.81
Pharmacological and clinical studies of cyclopyrrolones: zopiclone and suriclone. Pharmacol Biochem Behav (1985) 0.81
Ketoprofen (19.583 R.P.) (2-(3-benzoylphenyl)-propionic acid). Main pharmacological properties--outline of toxicological and pharmacokinetic data. Scand J Rheumatol Suppl (1976) 0.81
Further demonstration that [Pro9]-substance P is a potent and selective ligand of NK-1 tachykinin receptors. J Neurochem (1991) 0.81
In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci (1979) 0.80
Substance P and neurokinin A variations throughout the rat estrous cycle; comparison with ovariectomized and male rats: II. Trigeminal nucleus and cervical spinal cord. J Neurosci Res (1996) 0.80
[Activity on Trichomonas vaginalis and other chemotherapeutic properties of 1-(2-hydroxyethyl)-2-carbamoyl-5-nitropyrrole (15,960 RP)]. C R Acad Sci Hebd Seances Acad Sci D (1966) 0.79
Substance P and neurokinin A variations throughout the rat estrous cycle; comparison with ovariectomized and male rats: I. Plasma, hypothalamus, anterior and posterior pituitary. J Neurosci Res (1996) 0.79
Stimulatory effect of a specific substance P antagonist (RPR 100893) of the human NK1 receptor on the estradiol-induced LH and FSH surges in the ovariectomized cynomolgus monkey. J Neurosci Res (1997) 0.79
Linkage analysis in 16 families with incontinentia pigmenti. Eur J Hum Genet (1997) 0.79
Brain receptors and zopiclone. Int Pharmacopsychiatry (1982) 0.78
Dopamine metabolism in the mesolimbic and mesocortical dopaminergic systems after single or repeated administrations of neuroleptics. Brain Res (1976) 0.78
CGRP in the trigeminal nucleus, spinal cord and hypothalamus: effect of gonadal steroids. Neuropeptides (1996) 0.78
[Study of the pharmacological properties of 3-dimethylsulfonamido 10-(2-dimethylamino-propyl) phenothiazine (8.599 RP)]. Arch Int Pharmacodyn Ther (1966) 0.78
Evidence of electrogenicity of the sarcoplasmic reticulum Ca2+ pump as measured with flow dialysis method. FEBS Lett (1981) 0.78
Influence of cirrhosis on lamotrigine pharmacokinetics. Br J Clin Pharmacol (2001) 0.77
Antagonism of substance P and related peptides by RP 67580 and CP-96,345, at tachykinin NK1 receptor sites, in the rat urinary bladder. Eur J Pharmacol (1994) 0.77
Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cells. Eur J Pharmacol (1993) 0.77
Spinal effects of selective NK-1 and NK-2 receptor antagonists on bladder motility in anesthetized rats. Regul Pept (1993) 0.77
Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor. Mol Pharmacol (1994) 0.77
Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.76
Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig. Br J Pharmacol (1995) 0.75
Pharmacological studies on zopiclone. Int Pharmacopsychiatry (1982) 0.75
[Correlations between the results of pharmacokinetic and pharmacological studies on several pipotiazine esters]. Therapie (1974) 0.75
[General pharmacological properties of methiazinic acid (16091 RP)]. Arzneimittelforschung (1969) 0.75
[Experimental study of delayed-action injectable neuroleptics]. Actual Pharmacol (Paris) (1972) 0.75
The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--I. In vitro studies. Biochem Pharmacol (1980) 0.75
[Anti-inflammatory proprieties of (10-methyl 2-phenothiazinyl) acetic acid (16, 091 R.P.)]. C R Acad Sci Hebd Seances Acad Sci D (1967) 0.75
[Acid derivatives of phenothiazine. Preparation and study of relations between the chemical structure and anti-inflammatory action]. Arzneimittelforschung (1969) 0.75
On the interaction between neuroleptics and antiparkinson drugs. Mod Probl Pharmacopsychiatry (1970) 0.75
Labeling of cytoplasmic liver RNA by (6- 14 C)orotic and 5-fluoro(2- 14 C)orotic acids. Effect of several inhibitors. Eur J Biochem (1973) 0.75
Highly potent substance P antagonists substituted with beta-phenyl- or beta-benzyl-proline at position 10. Eur J Pharmacol (1994) 0.75
Pharmacological study of pipotiazine (19.366 R.P.) and its undecylenic (19.551 R.P.) and palmitic (19.552 R.P.) esters. Acta Psychiatr Scand Suppl (1973) 0.75
The use of thioproperazine, a phenothiazine derivative, as a ligand for neuroleptic receptors--II. In vivo studies. Biochem Pharmacol (1980) 0.75
Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.75
Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues. Int J Pept Protein Res (1993) 0.75
[Antiarrhythmic properties of 3-(2-hydroxy-3 isopropylamino-propoxy)-3 phenyl-2 isoindolinone-1, (RS, SR) in the dog]. C R Seances Acad Sci D (1979) 0.75
[Calpain II of rabbit skeletal muscle. Regulation of enzymatic activity: influence of the presence of membrane phospholipids on enzymatic autolysis in the presence or not of substrate]. Reprod Nutr Dev (1988) 0.75
The neuroleptics. 3. Pharmacology. Introduction. Mod Probl Pharmacopsychiatry (1970) 0.75
[A new antibiotic with antineoplastic activity: rubidomycin (13.057 R.P.). 3. Toxicological and pharmacological study]. Arzneimittelforschung (1967) 0.75
[Experimental kidney transplantation: a comparison between different models]. Minerva Chir (2003) 0.75
[Study of teratogenic acitivity of sodium oxyferriscorbone]. Ann Pharm Fr (1969) 0.75
[The biochemical effects of a new antidepressive, metapramine (RP 19560) on activity of the dopaminergic and cholinergic systems of the rat striatum]. J Pharmacol (1986) 0.75
[Comparative study of excreted substances in the urine of man and dogs after administration of dimethylsulfamido-3-(dimethylamino-2-propyl)-10-phenothiazine (dimethithiazine)]. Arch Int Pharmacodyn Ther (1968) 0.75
Acute and chronic treatment with neuroleptics: similarities and differences in their action on nigrostriatal, mesolimbic, and mesocortical dopaminergic neurons. Adv Biochem Psychopharmacol (1977) 0.75
RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent. J Pharmacol Exp Ther (1993) 0.75
Electrographic studies of the effects of RP 60180, a novel kappa agonist, on the photosensitive baboon Papio papio. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.75
[Not Available]. C R Seances Soc Biol Fil (1958) 0.75
[Histochemical study of experimental gastric lesions induced by acetylsalicylic acid and other drugs in rats]. Laval Med (1966) 0.75
[Toxicologic study of methiazinic acid (16091 R.P)]. Arzneimittelforschung (1969) 0.75
Relationship between the inhibitory activity on 'RCS' and prostaglandins synthesis and the anti-inflammatory activity of ketoprofen and several other non-steroidal anti-inflammatory agents. Rheumatol Rehabil (1976) 0.75
Effects of thioproperazine and apomorphine on dopamine synthesis in the mesocortical dopaminergic systems. Brain Res (1975) 0.75